Back to the Top
Dear All,
Does anyone know guidance which speak about wider range than 80-125% of
primary pk parmeters for PK-PD of monoclonal antibodies as this
conventional range is difficult to follow for monoclonals in phase 1 pk- PD
trials.
Best regards
Vishal Pavitrakar
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@lists.ucdenver.edu with "Range for mABs 80-125% (Phase 1 PKPD)" as the subject |
Copyright 1995-2014 David W. A. Bourne (david@boomer.org)